QQQ   309.24 (-0.16%)
AAPL   159.05 (+0.08%)
MSFT   279.18 (+0.55%)
META   205.86 (+0.77%)
GOOGL   105.07 (-0.50%)
AMZN   97.63 (-1.09%)
TSLA   189.36 (-1.49%)
NVDA   266.83 (-1.87%)
NIO   8.98 (-3.13%)
BABA   86.73 (+0.24%)
AMD   97.97 (-2.30%)
T   18.52 (+0.33%)
F   11.43 (+0.09%)
MU   61.12 (-0.36%)
CGC   1.92 (+0.52%)
GE   91.93 (+0.37%)
DIS   93.76 (-2.16%)
AMC   4.44 (-0.67%)
PFE   40.20 (+0.05%)
PYPL   73.50 (+1.30%)
NFLX   327.88 (+2.34%)
QQQ   309.24 (-0.16%)
AAPL   159.05 (+0.08%)
MSFT   279.18 (+0.55%)
META   205.86 (+0.77%)
GOOGL   105.07 (-0.50%)
AMZN   97.63 (-1.09%)
TSLA   189.36 (-1.49%)
NVDA   266.83 (-1.87%)
NIO   8.98 (-3.13%)
BABA   86.73 (+0.24%)
AMD   97.97 (-2.30%)
T   18.52 (+0.33%)
F   11.43 (+0.09%)
MU   61.12 (-0.36%)
CGC   1.92 (+0.52%)
GE   91.93 (+0.37%)
DIS   93.76 (-2.16%)
AMC   4.44 (-0.67%)
PFE   40.20 (+0.05%)
PYPL   73.50 (+1.30%)
NFLX   327.88 (+2.34%)
QQQ   309.24 (-0.16%)
AAPL   159.05 (+0.08%)
MSFT   279.18 (+0.55%)
META   205.86 (+0.77%)
GOOGL   105.07 (-0.50%)
AMZN   97.63 (-1.09%)
TSLA   189.36 (-1.49%)
NVDA   266.83 (-1.87%)
NIO   8.98 (-3.13%)
BABA   86.73 (+0.24%)
AMD   97.97 (-2.30%)
T   18.52 (+0.33%)
F   11.43 (+0.09%)
MU   61.12 (-0.36%)
CGC   1.92 (+0.52%)
GE   91.93 (+0.37%)
DIS   93.76 (-2.16%)
AMC   4.44 (-0.67%)
PFE   40.20 (+0.05%)
PYPL   73.50 (+1.30%)
NFLX   327.88 (+2.34%)
QQQ   309.24 (-0.16%)
AAPL   159.05 (+0.08%)
MSFT   279.18 (+0.55%)
META   205.86 (+0.77%)
GOOGL   105.07 (-0.50%)
AMZN   97.63 (-1.09%)
TSLA   189.36 (-1.49%)
NVDA   266.83 (-1.87%)
NIO   8.98 (-3.13%)
BABA   86.73 (+0.24%)
AMD   97.97 (-2.30%)
T   18.52 (+0.33%)
F   11.43 (+0.09%)
MU   61.12 (-0.36%)
CGC   1.92 (+0.52%)
GE   91.93 (+0.37%)
DIS   93.76 (-2.16%)
AMC   4.44 (-0.67%)
PFE   40.20 (+0.05%)
PYPL   73.50 (+1.30%)
NFLX   327.88 (+2.34%)
NASDAQ:TARS

Tarsus Pharmaceuticals - TARS Insider Trading & Ownership

$11.89
-0.25 (-2.06%)
(As of 03/24/2023 12:01 PM ET)
Add
Compare
Today's Range
$11.81
▼
$12.08
50-Day Range
$12.04
▼
$16.27
52-Week Range
$10.80
▼
$19.66
Volume
17,471 shs
Average Volume
71,893 shs
Market Capitalization
$317.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$41.00

Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
33.08%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$1.65 M
Number Of
Insiders Selling
(Last 12 Months)
10
Amount Of
Insider Selling
(Last 12 Months)
$3.11 M

TARS Insider Buying and Selling by Quarter

Get TARS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Tarsus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Tarsus Pharmaceuticals Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/22/2023Bobak R AzamianCEOSell709$12.64$8,961.769,334  
3/22/2023Bryan WahlGeneral CounselSell357$12.64$4,512.4816,773  
3/22/2023Jose M TrevejoInsiderSell529$12.64$6,686.566,572  
3/22/2023Leonard M GreensteinCFOSell332$12.64$4,196.4832,131  
3/22/2023Seshadri NeervannanCOOSell379$12.64$4,790.5655,086  
3/20/2023Bobak R AzamianCEOSell741$12.61$9,344.0110,722  
3/20/2023Bryan WahlGeneral CounselSell357$12.61$4,501.7717,480  
3/20/2023Jose M TrevejoInsiderSell530$12.61$6,683.307,620  
3/20/2023Leonard M GreensteinCFOSell333$12.61$4,199.1332,789  
3/20/2023Mark J HoldbrookVPSell198$12.61$2,496.783,191  
3/20/2023Seshadri NeervannanCOOSell380$12.61$4,791.8055,837  
3/17/2023Bobak R AzamianCEOSell795$13.28$10,557.6011,463  
3/16/2023Bryan WahlGeneral CounselSell337$13.43$4,525.9118,176  
3/16/2023Dianne C WhitfieldInsiderSell313$13.43$4,203.5912,872  
3/16/2023Leonard M GreensteinCFOSell5,313$13.44$71,406.7233,438  
3/16/2023Mark J HoldbrookVPSell187$13.43$2,511.413,577  
3/16/2023Seshadri NeervannanCOOSell357$13.43$4,794.5156,577  
3/15/2023Bobak R AzamianCEOSell8,000$13.79$110,320.001,080,536  
3/8/2023Bobak R AzamianCEOSell4,853$15.02$72,892.061,089,253  
2/8/2023Bobak R AzamianCEOSell9,000$15.14$136,260.001,102,106  
1/23/2023Bobak R AzamianCEOSell4,856$15.45$75,025.201,111,106  
1/20/2023Bobak R AzamianCEOSell240$15.00$3,600.001,116,373  
1/19/2023Leonard M GreensteinCFOSell5,000$14.56$72,800.0039,289  
1/18/2023Bobak R AzamianCEOSell8,000$14.56$116,480.001,116,613  
1/11/2023Bobak R AzamianCEOSell3,904$15.11$58,989.441,124,613  
1/9/2023Bobak R AzamianCEOSell729$15.15$11,044.351,129,422  
1/6/2023Bobak R AzamianCEOSell411$15.00$6,165.001,129,740  
12/21/2022Bobak R AzamianCEOSell8,000$14.57$116,560.001,130,151  
12/16/2022Bobak R AzamianCEOSell535$15.01$8,030.351,138,151  
12/15/2022Leonard M GreensteinCFOSell5,000$14.64$73,200.0044,289  
12/14/2022Bobak R AzamianCEOSell6,420$15.08$96,813.601,138,686  
12/2/2022Dianne C WhitfieldInsiderSell1,154$16.90$19,502.608,723  
11/30/2022Bryan WahlGeneral CounselSell1,183$16.50$19,519.5016,041  
11/30/2022Dianne C WhitfieldInsiderSell1,182$16.50$19,503.0011,042  
11/15/2022Aziz MottiwalaInsiderSell6,857$17.72$121,506.0449,729  
10/20/2022Leonard M GreensteinCFOSell5,000$15.92$79,600.0054,289  
10/19/2022Bobak R AzamianCEOSell8,000$16.92$135,360.001,162,106  
10/12/2022Bobak R AzamianCEOSell9,000$15.91$143,190.001,170,106  
9/21/2022Bobak R AzamianCEOSell8,000$16.31$130,480.001,179,106  
9/15/2022Leonard M GreensteinCFOSell5,000$16.03$80,150.0059,289  
9/14/2022Bobak R AzamianCEOSell9,000$16.01$144,090.001,187,106  
9/14/2022Elizabeth Yeu LinDirectorBuy18,400$16.12$296,608.0012,040  
8/18/2022Leonard M GreensteinCFOSell5,000$16.30$81,500.0064,289  
8/17/2022Bobak R AzamianCEOSell8,000$16.59$132,720.001,196,106  
5/5/2022Michael AckermannDirectorBuy100,000$13.50$1,350,000.00100,000  
5/4/2022Vivo Capital Ix, LlcMajor ShareholderSell19,738$12.67$250,080.462,474,375  
5/2/2022Vivo Capital Ix, LlcMajor ShareholderSell41,800$15.19$634,942.002,945,531  
(Data available from 1/1/2013 forward)












TARS Insider Trading Activity - Frequently Asked Questions

Who is on Tarsus Pharmaceuticals's Insider Roster?

The list of insiders at Tarsus Pharmaceuticals includes Aziz Mottiwala, Bobak R Azamian, Bryan Wahl, Dianne C Whitfield, Elizabeth Yeu Lin, Jason E Tester, Jose M Trevejo, Leonard M Greenstein, Mark J Holdbrook, Michael Ackermann, Rtw Investments, Lp, Seshadri Neervannan, Vivo Capital Fund Ix, L.P., and Vivo Capital Ix, Llc. Learn more on insiders at TARS.

What percentage of Tarsus Pharmaceuticals stock is owned by insiders?

33.08% of Tarsus Pharmaceuticals stock is owned by insiders. Learn more on TARS's insider holdings.

Which Tarsus Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased TARS shares in the last 24 months: Elizabeth Yeu Lin ($296,608.00), and Michael Ackermann ($1,350,000.00).

How much insider buying is happening at Tarsus Pharmaceuticals?

Insiders have purchased a total of 118,400 TARS shares in the last 24 months for a total of $1,646,608.00 bought.

Which Tarsus Pharmaceuticals insiders have been selling company stock?

The following insiders have sold TARS shares in the last 24 months: Aziz Mottiwala ($395,523.78), Bobak R Azamian ($1,734,846.25), Bryan Wahl ($33,059.66), Dianne C Whitfield ($43,209.19), Jose M Trevejo ($13,369.86), Leonard M Greenstein ($467,052.33), Mark J Holdbrook ($5,008.19), Michael Ackermann ($717,785.48), Rtw Investments, Lp ($13,491,000.00), Seshadri Neervannan ($14,376.87), and Vivo Capital Ix, Llc ($4,978,126.86).

How much insider selling is happening at Tarsus Pharmaceuticals?

Insiders have sold a total of 842,024 Tarsus Pharmaceuticals shares in the last 24 months for a total of $21,941,417.66 sold.

This page (NASDAQ:TARS) was last updated on 3/24/2023 by MarketBeat.com Staff